Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand

MT Newswires Live

昨天

Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.

The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.

The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2664385110"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664385110\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664385110?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-04 11:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664385110","market":"fut","top_or_hot":-1,"title":"Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand","media":"MT Newswires Live","content":"<html><body><p> Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.</p><p>The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.</p><p>The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. <a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvopoint Biosciences Adjusts IPO Allocation on Strong Online Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-04 11:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.</p><p>The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.</p><p>The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. <a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4127","symbol_name":"投资银行业与经纪业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2664385110","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664385110","pubTimestamp":1788491484,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Evopoint Biosciences  moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688837":"信诺维-U","BK4127":"投资银行业与经纪业","FRHC":"Euronext CAC Health Care","REDS":"RPM Republican Senate ETF","KCE":"SPDR KBW Capital Markets ETF","IPOS":"Renaissance International IPO ETF"},"translate_title":"Evopoint Biosciences 因在线需求强劲而调整 IPO 分配","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688837":0.9,"FRHC":1.5,"KCE":1.5,"REDS":1.5,"IPOS":1.5},"content_text":"Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}